Home Zacks Investment Research Upgrades QLT Inc. (QLTI) to "Buy"
 

Keywords :   


Zacks Investment Research Upgrades QLT Inc. (QLTI) to "Buy"

2016-01-18 04:09:42| Biotech - Topix.net

The firm presently has a $2.75 price objective on the stock. Zacks Investment Research 's target price suggests a potential upside of 13.64% from the stock's current price.

Tags: buy research investment upgrades

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
More »